Related Experiment Video

Updated: Aug 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Targeting the p53-MDM2 interaction to treat cancer

C Klein1, L T Vassilev

  • 1Pharma Research, Roche Diagnostics GmbH, Penzberg D-82372, Germany.

British Journal of Cancer
|September 29, 2004
PubMed

Insights

Targeting the p53-MDM2 interaction with small-molecule antagonists like Nutlins offers a promising cancer therapy strategy. These potent compounds reactivate the tumour suppressor p53, inhibiting cancer cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • The tumour suppressor p53 is crucial for anti-cancer activity.
  • MDM2 (mouse double minute 2) negatively regulates p53 by inhibiting its function and stability.
  • MDM2 is overexpressed in many cancers, making the p53-MDM2 interaction a key therapeutic target.

Purpose of the Study:

  • To explore the potential of targeting the p53-MDM2 interaction for cancer therapy.
  • To investigate the development of nonpeptidic MDM2 antagonists.

Main Methods:

  • Identification and characterization of small-molecule MDM2 antagonists.
  • Utilizing Nutlins, the first potent and selective MDM2 antagonists.
  • In vitro and in vivo studies to evaluate therapeutic efficacy.

Main Results:

  • Nutlins demonstrated potent and selective antagonism of MDM2.
  • Studies provided proof-of-principle for targeting the p53-MDM2 interaction.
  • Successful reactivation of p53's tumour-suppressive functions.

Conclusions:

  • Targeting the p53-MDM2 interaction is a viable strategy for cancer treatment.
  • Small-molecule MDM2 antagonists like Nutlins show significant therapeutic potential.
  • Further development of these antagonists could lead to novel cancer therapies.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...